Citation 7790

JODYNIS LIEBERT,J: MURIAS,M: BTOSZYK,E:. (2000). EFFECT OF SESQUITERPENE LACTONES ON ANTIOXIDANT ENZYMES AND SOME DRUG-METABOLIZING ENZYMES IN RAT LIVER AND KIDNEY.. 66(3)

Citation Details

Title	EFFECT OF SESQUITERPENE LACTONES ON ANTIOXIDANT ENZYMES AND SOME DRUG-METABOLIZING ENZYMES IN RAT LIVER AND KIDNEY.
Authors	JODYNIS LIEBERT,J: MURIAS,M: BTOSZYK,E:
Year	2000
Volume	66
Issue	3

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
2	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	INACTIVE
3	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
4	GLUTATHIONE REDUCTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	WEAK ACTIVITY
5	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
6	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
7	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
8	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
9	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	INACTIVE
10	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	WEAK ACTIVITY
11	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	WEAK ACTIVITY
12	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	INACTIVE
13	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
14	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
15	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
16	AMINOPYRINE-N-DEMETHYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
17	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
18	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
19	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	INACTIVE
20	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	INACTIVE
21	AMINOPYRINE-N-DEMETHYLASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	INACTIVE
22	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HELENALIN	ACTIVE
23	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
24	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	INACTIVE
25	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
26	GLUTATHIONE REDUCTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
27	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
28	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
29	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	INACTIVE
30	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
31	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	INACTIVE
32	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	WEAK ACTIVITY
33	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	INACTIVE
34	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	INACTIVE
35	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
36	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
37	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
38	AMINOPYRINE-N-DEMETHYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
39	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
40	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEXICANIN I	ACTIVE
41	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	WEAK ACTIVITY
42	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
43	AMINOPYRINE-N-DEMETHYLASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	INACTIVE
44	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MEXICANIN I	ACTIVE
45	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	ACTIVE
46	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	INACTIVE
47	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	ACTIVE
48	GLUTATHIONE REDUCTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	WEAK ACTIVITY
49	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	INACTIVE
50	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	ACTIVE
51	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	INACTIVE
52	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	ACTIVE
53	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	INACTIVE
54	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	WEAK ACTIVITY
55	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	INACTIVE
56	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	ACTIVE
57	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	INACTIVE
58	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	ACTIVE
59	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	ACTIVE
60	AMINOPYRINE-N-DEMETHYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	WEAK ACTIVITY
61	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	ACTIVE
62	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	INACTIVE
63	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	WEAK ACTIVITY
64	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	ACTIVE
65	AMINOPYRINE-N-DEMETHYLASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	WEAK ACTIVITY
66	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GEIGERININ	ACTIVE
67	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
68	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	INACTIVE
69	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
70	GLUTATHIONE REDUCTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	WEAK ACTIVITY
71	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	INACTIVE
72	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
73	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
74	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
75	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	INACTIVE
76	GLUTATHIONE REDUCTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	WEAK ACTIVITY
77	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	WEAK ACTIVITY
78	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
79	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
80	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
81	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
82	AMINOPYRINE-N-DEMETHYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
83	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
84	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
85	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	WEAK ACTIVITY
86	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
87	AMINOPYRINE-N-DEMETHYLASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
88	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LINIFOLIN A	ACTIVE
89	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
90	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
91	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
92	GLUTATHIONE REDUCTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
93	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
94	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	WEAK ACTIVITY
95	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	INACTIVE
96	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
97	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	INACTIVE
98	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	WEAK ACTIVITY
99	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	WEAK ACTIVITY
100	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	INACTIVE
101	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	INACTIVE
102	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
103	ANILINE HYDROXYLASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
104	AMINOPYRINE-N-DEMETHYLASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
105	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	INACTIVE
106	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	INACTIVE
107	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	WEAK ACTIVITY
108	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	INACTIVE
109	AMINOPYRINE-N-DEMETHYLASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
110	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	AROMATICIN,2-3-DIHYDRO: 6-ALPHA-HYDROXY:	ACTIVE
111	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	ACTIVE
112	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	WEAK ACTIVITY
113	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	ACTIVE
114	GLUTATHIONE REDUCTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	ACTIVE
115	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	ACTIVE
116	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	WEAK ACTIVITY
117	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	INACTIVE
118	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	INACTIVE
119	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	INACTIVE
120	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	INACTIVE
121	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	WEAK ACTIVITY
122	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	ACTIVE
123	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	INACTIVE
124	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	ACTIVE
125	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	WEAK ACTIVITY
126	AMINOPYRINE-N-DEMETHYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	INACTIVE
127	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	INACTIVE
128	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	INACTIVE
129	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	WEAK ACTIVITY
130	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	WEAK ACTIVITY
131	AMINOPYRINE-N-DEMETHYLASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	INACTIVE
132	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPERILIN	WEAK ACTIVITY
133	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	ACTIVE
134	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	WEAK ACTIVITY
135	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	ACTIVE
136	GLUTATHIONE REDUCTASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	WEAK ACTIVITY
137	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	WEAK ACTIVITY
138	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	ACTIVE
139	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	INACTIVE
140	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	INACTIVE
141	GLUTATHIONE PEROXIDASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	INACTIVE
142	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	WEAK ACTIVITY
143	CATALASE STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	INACTIVE
144	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	ACTIVE
145	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	INACTIVE
146	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	ACTIVE
147	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	ACTIVE
148	AMINOPYRINE-N-DEMETHYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	INACTIVE
149	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	INACTIVE
150	CYTOCHROME P450 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	INACTIVE
151	NADPH-CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	WEAK ACTIVITY
152	ANILINE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	INACTIVE
153	AMINOPYRINE-N-DEMETHYLASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	INACTIVE
154	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TELEKIN	WEAK ACTIVITY

Citation 7790

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1